Optimizing therapy of seizures in children and adolescents with ADHD

Neurology

Volumn 67, Issue 12 SUPPL. 4, 2006, Pages

  Aldenkamp, Albert P ^a,b   Arzimanoglou, Alexis ^c   Reijs, Rianne ^a,b   Van Mil, Saskia ^a  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; METHYLPHENIDATE; PHENOBARBITAL; PSYCHOSTIMULANT AGENT; VALPROIC ACID;

ANGER; ANTICONVULSANT THERAPY; ATTENTION DEFICIT DISORDER; CHILDHOOD; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; EPILEPSY; GENETIC PREDISPOSITION; HUMAN; HYPERACTIVITY; IRRITABILITY; MENTAL DEFICIENCY; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SEDATION; SEIZURE; SIDE EFFECT;

EID: 33845690699     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.12_suppl_4.s49     Document Type: Review

References (33)

1. Schuerholz LJ, Cutting L, Mazzocco MM, Singer HS, Dencla MB. Neuromotor functioning in children with Tourette syndrome with and without attention deficit hyperactivity disorder. J Child Neurol 1997;12:438-442.
2. Berman T, Douglas VI, Barr RG. Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder. J Abnorm Psychol 1999;108:90-105.
3. Loisier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 1996;37:971-987.
4. Carter ET, Nigg JT, Hinshaw SP. Neuropsychological functioning, motor speed, and language processing in boys with and without ADHD. J Abnorm Child Psychol 1996;24:481-498.
5. Richards GP, Samuels SJ, Turnure JE, Yssedyke JE. Sustained and selective attention in children with learning disabilities. J Learning Disab 1990;23:129-136.
6. Swanson JM, Posner M, Potkin S, et al. Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach. J Child Neurol 1991;6:119-127.
7. Levy F, Hobbes G. Discrimination of attention deficit hyperactivity disorder by the continuous performance test. J Paediatr Health 1997;33:384-387.
8. Biederman J Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237-248.
9. Semrud-Clikeman M, Wical B. Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40:211-215.
10. Corkum PV, Siegel LS. Is the continuous performance task a valuable research tool for use with children with attention-deficit-hyperactivity disorder? J Child Psychol Psychiatry 1993;34:1217-1239.
11. Rowland AS, Umbach DM, Catoe KE, et al. Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. Can J Psychiatry 2001;46:931-940.
12. Gucuyener K, Erdemoglu AK, Senol, S, Serdaoglu A, Soyosal S, Kockar AI. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy. J Child Neurol 2003;18:109-113.
13. Dunn D, Austin J, Harezlak J, Ambrosius W. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003;45:50-54.
14. Schubert R. Attention deficit disorder and epilepsy. Pediatr Neurol 2005;32:1-10.
15. Gross-Tsur V, Manor O, Van der Meere J, Joseph A, Shalev RS. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J Pediatr 1997;130:40-44.
16. Tan M, Appleton R. Attention deficit and hyperactivity disorder, methylphenidate and epilepsy. Arch Dis Child 2005;90:57-59.
17. Aldenkamp AP, Arends J. The relative influence of epileptic EEG discharges, short nonconvulsive seizures and type of epilepsy on cognitive function. Epilepsia 2004;45:54-63.
18. Reijs R, Aldenkamp AP, De Krom M. Mood effects of antiepileptic drugs. Epilepsy Behav 2004;5:66-67.
19. Hesdorffer DC, Ludvigsson P, Olafsson E, Gudmundsson G, Kjartansson O, Hauser WA. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61:731-736.
20. Stein MA, Blondis TA, Schnitzler ER. Methylphenidate dosing: twice daily versus three times daily. Pediatrics 1996;98:748-756.
21. Physicians Desk Reference 1998. 52nd ed. Montvale, NJ: Medical Economics Company, 1997.
22. Feldman H, Crumrine P, Handen BL, Alvin R, Teodori J. Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 1989;143:1081-1086.
23. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001;24:99-102.
24. Smith DB, Mattson RH, Cramer JA. Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987;28:50-58.
25. Vining EP, Mellitis ED, Dorsen MM, et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-174.
26. Ingram TTS. A characteristic form of overactive behaviour in brain damaged children. J Ment Sci 1986;102:550-558.
27. Wolf SM, Forsythe A. Behavior disturbance, phenobarbital and febrile seizures. Pediatrics 1978;61:728-731.
28. Committee of Drugs. Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics 1985;76:644-647.
29. Corbett JA, Trimble MR, Nichol TC. Behavioral and cognitive impairments in children with epilepsy: the long-term effect of anticonvulsant therapy. J Am Acad Child Psychiatry 1985;24:17-23.
30. Trimble MR, Cull C. Children of school age: the influence of antiepileptic drugs on behavior and intellect. Epilepsia 1988;29:15-19.
31. Herranz JL, Arteaga R, Armijo JA. Side-effects of sodium valproate in monotherapy, controlled by plasma levels: a study of 88 pediatric patients. Epilepsia 1982;23:203-214.
32. Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53(5 suppl 2):53-67.
33. Ettinger AB, Weisbrot DM, Saracco J, Dhoon A, Kanner A, Devinsky O. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998;39:874-877.